In this Fig. 2, there are 8 small sub-figures for 8 different tissues. Of these, one sub-figure (Stomach, left panel, top) has been revised (open and filled symbols switched for the stomach only), and the rest 7 tissues are and unchanged. The figure legend is also unchanged.
Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.